Oncotarget

Vol 9, No 69

September 4, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 69 of Oncotarget features Figure 5, "qRT-PCR analysis of select mRNAs in mTORC1/2 inhibited cells with and without carboplatin treatment," by David-West, et al.

Table of Contents

News

CALPA-IN NF1

CALPA-IN NF1

https://doi.org/10.18632/oncotarget.25990

Ikrame Lazar,  and Ze’ev A. Ronai
33051-33051
PDF  |  Order a Reprint

CpG island hypermethylation go circular (RNA)

CpG island hypermethylation go circular (RNA)

https://doi.org/10.18632/oncotarget.26074

Mihnea P. Dragomir,  and George A. Calin
33052-33053
PDF  |  Order a Reprint

Editorial

Checks and balances occur not only in government, but also in biology

Checks and balances occur not only in government, but also in biology

https://doi.org/10.18632/oncotarget.25876

John T. Isaacs
33054-33055
PDF  |  Order a Reprint

MACROD2 deletions cause impaired PARP1 activity and chromosome instability in colorectal cancer

MACROD2 deletions cause impaired PARP1 activity and chromosome instability in colorectal cancer

https://doi.org/10.18632/oncotarget.25887

Anuratha Sakthianandeswaren, Marie J. Parsons, Dmitri Mouradov,  and Oliver M. Sieber
33056-33058
PDF  |  Order a Reprint

177Lutetium-Dotatate delays decline in quality of life in patients with midgut neuroendocrine tumors

177Lutetium-Dotatate delays decline in quality of life in patients with midgut neuroendocrine tumors

https://doi.org/10.18632/oncotarget.25942

Jonathan Strosberg
33059-33059
PDF  |  Order a Reprint

Prognostic markers for colorectal cancer

Prognostic markers for colorectal cancer

https://doi.org/10.18632/oncotarget.26012

Helen E.J. Tyrrell,  and David Kerr
33060-33061
PDF  |  Order a Reprint

Commentaries

Population based germline testing for primary cancer prevention

Population based germline testing for primary cancer prevention

https://doi.org/10.18632/oncotarget.25995

Ranjit Manchanda,  and Rosa Legood
33062-33063
PDF  |  Order a Reprint

Priority Research Papers

mTORC1/2 inhibition re-sensitizes platinum-resistant ovarian cancer by disrupting selective translation of DNA damage and survival mRNAs

mTORC1/2 inhibition re-sensitizes platinum-resistant ovarian cancer by disrupting selective translation of DNA damage and survival mRNAs

https://doi.org/10.18632/oncotarget.25869

Gizelka David-West, Amanda Ernlund, Abhilash Gadi,  and Robert J. Schneider
33064-33076
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Research Papers

Distinct urinary glycoprotein signatures in prostate cancer patients

Distinct urinary glycoprotein signatures in prostate cancer patients

https://doi.org/10.18632/oncotarget.26005

Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen,  and Giuseppe Palmisano
33077-33097
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma

Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma

https://doi.org/10.18632/oncotarget.26006

Hunter John Piegols, Marilia Takada, Maciej Parys, Thomas Dexheimer,  and Vilma Yuzbasiyan-Gurkan
33098-33109
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth

The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth

https://doi.org/10.18632/oncotarget.26011

Janet K. Parrish, Tyler S. McCann, Marybeth Sechler, Lays M. Sobral, Wen Hua Ren, Kenneth L. Jones, Aik Choon Tan,  and Paul Jedlicka
33110-33123
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Fludarabine-resistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia

Fludarabine-resistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia

https://doi.org/10.18632/oncotarget.26043

Chunfa Huang, Yifan Tu,  and Carl E. Freter
33124-33137
Abstract  |  PDF  |  HTML  |  Order a Reprint

Trisenox disrupts MDM2-DAXX-HAUSP complex and activates p53, cell cycle regulation and apoptosis in acute leukemia cells

Trisenox disrupts MDM2-DAXX-HAUSP complex and activates p53, cell cycle regulation and apoptosis in acute leukemia cells

https://doi.org/10.18632/oncotarget.26025

Sanjay Kumar, Andrea Brown,  and Paul B. Tchounwou
33138-33148
Abstract  |  PDF  |  HTML  |  Order a Reprint

Comprehensive analysis identifying aberrant DNA methylation in rectal mucosa from ulcerative colitis patients with neoplasia

Comprehensive analysis identifying aberrant DNA methylation in rectal mucosa from ulcerative colitis patients with neoplasia

https://doi.org/10.18632/oncotarget.26032

Yuji Toiyama, Yoshinaga Okugawa, Satoru Kondo, Yoshiki Okita, Toshimitsu Araki, Kurando Kusunoki, Motoi Uchino, Hiroki Ikeuchi, Seiichi Hirota, Akira Mitsui, Kenji Takehana, Tsutomu Umezawa,  and Masato Kusunoki
33149-33159
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG’s receptor ILT2 on peripheral CD8+ T cells

Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG’s receptor ILT2 on peripheral CD8+ T cells

https://doi.org/10.18632/oncotarget.26036

Francois Desgrandchamps, Joel LeMaoult, Annabelle Goujon, Adrien Riviere, Antonio Rivero-Juarez, Malika Djouadou, Amory de Gouvello, Clement Dumont, Ching-Lien Wu, Stephane Culine, Jerome Verine, Nathalie Rouas-Freiss, Christophe Hennequin, Alexandra Masson-Lecomte,  and Edgardo D. Carosella
33160-33169
Abstract  |  PDF  |  HTML  |  Order a Reprint

Autotaxin-β interaction with the cell surface via syndecan-4 impacts on cancer cell proliferation and metastasis

Autotaxin-β interaction with the cell surface via syndecan-4 impacts on cancer cell proliferation and metastasis

https://doi.org/10.18632/oncotarget.26039

Raphael Leblanc, Debashish Sahay, Audrey Houssin, Irma Machuca-Gayet,  and Olivier Peyruchaud
33170-33185
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth

miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth

https://doi.org/10.18632/oncotarget.26046

Nagindra Prashad
33186-33201
Abstract  |  PDF  |  HTML  |  Order a Reprint

Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family

Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family

https://doi.org/10.18632/oncotarget.26059

José Navarro-Fernández, María Eugenia de la Morena-Barrio, Emma Martínez-Alonso, Ingunn Dybedal, Mara Toderici, Nataliya Bohdan, Antonia Miñano, Ketil Heimdal, Ulrich Abildgaard, José Ángel Martínez-Menárguez, Javier Corral,  and Vicente Vicente
33202-33214
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Hematopoietic stem cell specific V-ATPase controls breast cancer progression and metastasis via cytotoxic T cells

Hematopoietic stem cell specific V-ATPase controls breast cancer progression and metastasis via cytotoxic T cells

https://doi.org/10.18632/oncotarget.26061

Manoranjan Sahoo, Gajendra K. Katara, Mahmood Y. Bilal, Safaa A. Ibrahim, Arpita Kulshrestha, Sara Fleetwood, Kimiko Suzue,  and Kenneth D. Beaman
33215-33231
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic

Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic

https://doi.org/10.18632/oncotarget.26075

Vikas Dembla, Neeta Somaiah, Pedro Barata, Kenneth Hess, Siqing Fu, Filip Janku, Daniel D. Karp, Aung Naing, Sarina Anne Piha-Paul, Vivek Subbiah, Apostolia M. Tsimberidou, Kenna Shaw, Funda Meric-Bernstam,  and David S. Hong
33232-33243
Abstract  |  PDF  |  HTML  |  Order a Reprint

Corrections

Correction: Antibody targeting TSPAN12/β-catenin signaling in vasoproliferative retinopathy

Correction: Antibody targeting TSPAN12/β-catenin signaling in vasoproliferative retinopathy

https://doi.org/10.18632/oncotarget.26102

Felicitas Bucher, Martin Friedlander,  and Kyungmoo Yea
33244-33244
Correction  |  PDF


Copyright © 2018 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC